As myotubular myopathy is linked to loss of the MTM1 protein and/or activity and an increase in the levels of PtdIns3P (21–25), previous studies tested whether modulation of different PI3K isoforms could normalize PI levels in MTM1 loss-of-function models. The gene discussed is MTM1; the disease is centronuclear myopathy.